BridgeMD
New treatment option for Abdominal Obesity
Official title Evaluation of Exercise Capacity in Teenage Females Using Virtual Reality and Plyometric Workout
ClinicalTrials.gov ID: NCT07092228
What this study is testing
- What it's testing
- to evaluate the efficacy of virtual reality combined with plyometric workout on abdominal obesity in adolescent females
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 18, women only. Healthy volunteers may be eligible.
You may be able to join if
- Body mass index more than or equal to 30 Kg/cm2
- waist circumference more than 80 cm
- medical history of polycystic ovarian syndrome
- Age from 13 to 18 years
You likely can't join if
- uncontrolled hypertension
- Rheumatoid arthritis
- Any respiratory diseases like Asthma and respiratory infections
- Osteoprosis
The study team makes the final eligibility decision.
Where it's taking place
- Ismailia, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 13 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ismailia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.